basaglar kwikpen

Generic: insulin glargine

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name basaglar kwikpen
Generic Name insulin glargine
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

insulin glargine 100 [iU]/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-7715
Product ID 0002-7715_3c2283e6-2844-44d2-a447-579b07e77c27
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA205692
Listing Expiration 2027-12-31
Marketing Start 2015-12-16

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00027715
Hyphenated Format 0002-7715

Supplemental Identifiers

RxCUI
847230 1736863 2268064 2268065
UNII
2ZM8CX04RZ
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name basaglar kwikpen (source: ndc)
Generic Name insulin glargine (source: ndc)
Application Number BLA205692 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01)
  • 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE
source: ndc

Packages (2)

0002-7715-59 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01) 0002-7715-63 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE

Ingredients (1)

insulin glargine (100 [iU]/mL)

Linked Drug Pages (1)

BASAGLAR KwikPen, BASAGLAR Tempo Pen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "3c2283e6-2844-44d2-a447-579b07e77c27", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["847230", "1736863", "2268064", "2268065"], "spl_set_id": ["0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-7715-59)  / 3 mL in 1 SYRINGE (0002-7715-01)", "package_ndc": "0002-7715-59", "marketing_start_date": "20160617"}, {"sample": true, "description": "1 SYRINGE in 1 CARTON (0002-7715-63)  / 3 mL in 1 SYRINGE", "package_ndc": "0002-7715-63", "marketing_start_date": "20160715"}], "brand_name": "BASAGLAR KwikPen", "product_id": "0002-7715_3c2283e6-2844-44d2-a447-579b07e77c27", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0002-7715", "generic_name": "Insulin glargine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BASAGLAR", "brand_name_suffix": "KwikPen", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 [iU]/mL"}], "application_number": "BLA205692", "marketing_category": "BLA", "marketing_start_date": "20151216", "listing_expiration_date": "20271231"}